Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
JAMA Oncology|October 16, 2025
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus ReviewCésar Serrano, Sebastian Bauer, Jean-Yves Blay, et al.
Therapeutic Advances in Medical Oncology|November 6, 2024
Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcomaJosé L Mondaza-Hernandez, Nadia Hindi, Antonio Fernandez-Serra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2024
A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient TumorsJ Andrew Livingston, Jean-Yves Blay, Jonathan Trent, et al.
Journal of the National Cancer Institute|January 27, 2017
Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer PatientsEnrique Gonzalez-Billalabeitia, Daniel Castellano, Nora Sobrevilla, et al.
International Journal of Cancer|May 16, 2018
Whole exome sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancerBeatriz Paumard-Hernández, Oriol Calvete, Lucia Inglada Pérez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2024
Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC TrialDavid S Moura, Jesus M Lopez-Marti, Iva Benesova, et al.
Cancer Communications (London, England)|March 16, 2026
IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma CohortJavier Martin-Broto, Sandra J Strauss, Emanuela Palmerini, et al.
Molecular Cancer|August 9, 2023
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trialJavier Martin-Broto, Claudia Valverde, Nadia Hindi, et al.
Molecular Cancer Therapeutics|September 23, 2021
Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III TrialJavier Martin-Broto, Maria Lopez-Alvarez, David S Moura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2025
Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) TrialsEmanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.
Pageof 7